Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT05490251
Official study title

Translational Research Center in Lung Cancer Disparities (TRACER) Project 2

Study summary

The purpose of this study is to examine racial differences in smoking behaviors and stress responses between African American and white male smokers.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forSmoking · Smoking Behaviors

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jun 3, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Virginia Commonwealth University

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Virginia Commonwealth University
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • African American and white males
  • Between the ages of 18-75 years old
  • Smoke at least 5 to 10 cigarettes per day
Reasons someone may not be able to joinExclusion criteria
  • Smokers who have a serious cognitive disorder
  • Have a personal history of lung cancer
  • Personal history of usage of illicit drug and alcohol abuse
  • Enrollment in a smoking cessation treatment program during the past 6 months
  • Current use of a nicotine replacement therapy
  • Have any positive responses on the Mini International Neuropsychiatric Interview (MINI) screener

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Southern CaliforniaLos Angeles, California
  • Medical University of South CarolinaCharleston, South Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 3, 2026. Always confirm current availability with the study team.

View original record ↗